Letter to the editor in reference to article titled: Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes

被引：0
|
作者：
Pokharna, H. [1 ]
Kanna, B. [1 ]
机构：
[1] Cornell Univ, Weill Med Coll, Lincoln Med & Mental Hlth Ctr, Bronx, NY USA
来源：
DIABETES OBESITY & METABOLISM | 2007年 / 9卷 / 06期
关键词：
D O I：
10.1111/j.1463-1326.2007.00721.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：914 / 914
页数：1
相关论文
共 50 条
  • [41] Triple combination therapy with sitagliptin, metformin, and rosiglitazone improves glycemic control in patients with type 2 diabetes
    Dobs, Adrian
    Goldstein, Barry J.
    Wieczorek, Leon
    Golm, Gregory
    Davies, Michael J.
    Williams-Herman, Debora
    Kaufman, Keith D.
    Amatruda, John M.
    Camilo, Juan
    Ferriera, Arjona
    [J]. DIABETES, 2008, 57 : A595 - A596
  • [42] Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus - A randomized controlled trial
    Fonseca, V
    Rosenstock, J
    Patwardhan, R
    Salzman, A
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (13): : 1695 - 1702
  • [43] Rosiglitazone-metformin combination therapy improves glycemic control in Mexican patients with Type 2 diabetes
    Gomez-Perez, FJ
    Fanghanel-Salmon, G
    Berry, RA
    Warsi, G
    Gould, EM
    [J]. DIABETES, 2001, 50 : A436 - A436
  • [44] Triple combination therapy with sitagliptin, metformin, and rosiglitazone improves glycaemic control in patients with type 2 diabetes
    Ferreira, J. C. Arjona
    Dobs, A.
    Goldstein, B. J.
    Wieczorek, L.
    Golm, G.
    Davies, M. J.
    Williams-Herman, D.
    Kaufman, K. D.
    Amatruda, J. M.
    [J]. DIABETOLOGIA, 2008, 51 : S365 - S365
  • [45] Rosiglitazone in combination with metformin effectively reduces hyperglycemia in patients with type 2 diabetes.
    Fonseca, V
    Biswas, N
    Salzman, A
    [J]. DIABETOLOGIA, 1999, 42 : A230 - A230
  • [46] Comparison of efficiency of rosiglitazone, metformin or glyburide monotherapy in patients with newly detected diabetes of type 2
    Sosnowski, Cezary
    Janeczko-Sosnowska, Ewa
    [J]. KARDIOLOGIA POLSKA, 2007, 65 (02) : 214 - 216
  • [47] Treatment Compliance with Fixed-Dose Combination of Vildagliptin/Metformin in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin Monotherapy: A 24-Week Observational Study
    Rombopoulos, Grigorios
    Hatzikou, Magdalini
    Athanasiadis, Athanasios
    Elisaf, Moyses
    [J]. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2015, 2015
  • [48] Acarbose plus metformin fixed-dose combination in the management of type 2 diabetes
    Joshi, Shashank R.
    Ramachandran, Ambady
    Chadha, Manoj
    Chatterjee, Sudip
    Rathod, Rahul
    Kalra, Sanjay
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (11) : 1611 - 1620
  • [49] Fixed-dose combinations in type 2 diabetes - role of the canagliflozin metformin combination
    Fleming, Joshua W.
    Fleming, Laurie W.
    Davis, Courtney S.
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2015, 8 : 287 - 294
  • [50] Glyburide*/metformin tablets versus metformin plus rosiglitazone in type 2 diabetes patients uncontrolled on metaformin: Attaining glycemic goals
    Garber, A
    Sankoh, S
    Mohideen, P
    Bruce, S
    [J]. DIABETES, 2003, 52 : A119 - A120
12345